New Bloom lab in the Chicago area will serve as a foothold in the midwestern United States
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) (“Bloom” or the “Company”), a leading provider of operational health and health technology, announces the opening of a new location in the Chicago area.
The new location provides expanded laboratories for operational health services and diagnostic testing to meet continued demand. As part of this expansion, Bloom has also added a local team. The Chicago location will serve film/TV productions in addition to new opportunities with Fortune 500 and organizations in the surrounding area.
“Our Chicago presence will support our growth plans in one of America’s busiest business regions,” said Andrew Morton, CEO of Bloom. “We’re focused on growing occupational health-tech for our clients. With supporting facilities in key hub cities like Dallas, Atlanta and now Chicago, Bloom is well-positioned to support current and future clients in strategic markets.”
Bloom also announces it has closed the third and final tranche of its previously announced non-brokered private placement offering (the “Offering“) and has issued 375,000 units (the “Units“) at $0.20 per Unit for gross proceeds of C$75,000. Combined with the first and second tranche of the Offering, the Company has issued 8,295,000 Units for aggregate gross proceeds of C$1,659,000. The Units are comprised of (i) one (1) common share in the capital of the Company (“Common Shares“); and (ii) one-half (1/2) of a transferable common share purchase warrant (each whole warrant, a “Warrant” and collectively, the “Warrants“). Each Warrant entitles the holder thereof to acquire one (1) additional Common Share (each, a “Warrant Share“) in the capital of the Company at a price of $0.30 per Warrant Share until December 26, 2023. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.
In connection with closing the third tranche of the Offering, the Company paid C$4,500 and issued 22,500 Warrants, exercisable at a price of $0.30 per Warrant Share until December 26, 2023 to an arms-length party who assisted in introducing subscribers to the Offering. All securities issued in connection with the Offering are subject to a statutory hold period until December 26, 2022 in accordance with applicable securities laws.
About Bloom Health Partners Inc.
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that “unstoppable is possible” for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.
For more information: info@bloomhealthpartners.com
On behalf of the board of directors,
Andrew Morton, Chief Executive Officer
Forward-Looking Statements
This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company’s forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company’s filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S.
